Influence of proteasome inhibitor bortezomib on the expression of multidrug resistance genes and Akt kinase activity
โ Scribed by L. A. Panischeva; E. S. Kakpakova; E. Y. Rybalkina; A. A. Stavrovskaya
- Book ID
- 110155622
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 469 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0006-2979
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Selective tyrosine kinase inhibitors are regarded as promising antitumor agents for cancer treatment. Iressaยฎ (ZD1839) is an orally active, selective EGFRโTKI (epidermal growth factor receptorโtyrosine kinase inhibitor) that blocks signal transduction pathways implicated in cancer cell
## Abstract The human mast cell line (HMCโ1^560^) was used to study the effects of tyrosine kinase (TyrK) inhibition on histamine release in consequence of intracellular Ca^2+^ or pH changes. This is important since the TyrK inhibitor STI571 (Glivecยฎ) inhibits proliferation and induces apoptosis in